We also note that dramatic therapeutic progress in other sarcomas, particularly in GIST (which are also genomically noncomplex), was achieved with the use of a single, representative, model of oncogenic KIT-dependency [49]. This evidence concerns the gene KIT and gastrointestinal stromal tumor.